Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

When to take the keys from aging parents

Figuring out when it’s time for a loved one to stop driving is a challenge many families face. While you don’t...

Read more »

Fraser recertified as civil trial attorney
Andrew A. Fraser, Partner with Sussex County law firm, Laddey Clark & Ryan LLP and Leader of the firm’s Personal Injury...
Read more »
Image

Underage drinking in county decreasing
The Center for Prevention and Counseling has been committed to providing evidence-based prevention programs and services...
Read more »
Image

Employment continues to advance
New Jersey’s unemployment rate edged lower by 0.1 percentage point to 4.1 percent for...
Read more »

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers



MOST READ

Local News
Employment continues to advance
  • Dec 7, 2018
Local News
Overshadowed by opioids, meth is back
  • Dec 5, 2018

MOST COMMENTED



Weather in Lafayette, NJ